Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

about

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

Item

http://www.wikidata.org/entity/Q56797729

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 09 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

@en

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

@nl

type

Item

label

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

@en

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

@nl

prefLabel

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

@en

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

@nl

P1476

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

@en

P2093

Ana P Castaño

http://www.w3.org/2001/XMLSchema#string

Darrell J Irvine

http://www.w3.org/2001/XMLSchema#string

Emily K Jeng

http://www.w3.org/2001/XMLSchema#string

Hing C Wong

http://www.w3.org/2001/XMLSchema#string

Llian Mabardi

http://www.w3.org/2001/XMLSchema#string

Mariane Bandeira Melo

http://www.w3.org/2001/XMLSchema#string

Na Li

http://www.w3.org/2001/XMLSchema#string

Yu-Qing Xie

http://www.w3.org/2001/XMLSchema#string

P2860

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

Initiation of T cell signaling by CD45 segregation at 'close contacts'

Remote control of therapeutic T cells through a small molecule-gated chimeric receptor.

Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study

Chimeric antigen receptor T cells for sustained remissions in leukemia

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation

PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses

Protein adsorption and cell adhesion on nanoscale bioactive coatings formed from poly(ethylene glycol) and albumin microgels.

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

P2888

nbt.4181

P304

707-716

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NBT.4181

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29985479

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

biomedical engineering

P932

6078803

http://www.w3.org/2001/XMLSchema#string